Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.
Company Profile
Industry Classifications
Sector
Healthcare
Industry
Biotechnology
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro And In Vivo Diagnostic Substances (2835)
Contact Information
Investor Relations
Nicole Jones
T: 425-686-1510
ir@achievelifesciences.com
Company Contact
Achieve Life Sciences, Inc.
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
T: 425-686-1500